Original Source(s)
Related Content
Why FDA Said No to a Melanoma Drug
Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.
by Arthur Allen
May 15, 2026
-
9 min
Vaginal DNA Assay Shows Promise
A two-marker methylated DNA assay identified endometrial cancer with 96% sensitivity in self-collected vaginal fluid — but prospective validation is needed before it can reduce biopsies in routine care.
by Kerri Miller
May 8, 2026
-
14 min
DNA Quality Outweighs Bone Source
Background DNA burden was more strongly associated with sequencing profile completeness than bone source in unidentified human remains.
May 19, 2026
-
5 min
